Du Haoyi, Li Danyang, Molive Laura Monjowa, Wu Na
Department of Endocrinology, Shengjing Hospital of China Medical University, Shenyang, 110004, People's Republic of China.
Medical Department, Shengjing Hospital of China Medical University, Liaoning Province, Shenyang, People's Republic of China.
J Transl Med. 2024 Feb 19;22(1):180. doi: 10.1186/s12967-024-04922-4.
The morbidity of gestational diabetes mellitus (GDM) is increasing and is associated with adverse perinatal outcomes and long-term maternal and infant health. The exact mechanism underlying changes in plasma free fatty acid (FFA) profiles in patients with GDM is unknown. However, it is believed that changes in diet and lipid metabolism may play a role. Fatty acids contain many specific FFAs, and the type of FFA has different impacts on physiological processes; hence, determining changes in FFAs in individual plasma is essential. Alterations in FFA concentration or profile may facilitate insulin resistance. Additionally, some FFAs show potential to predict GDM in early pregnancy and are strongly associated with the growth and development of the fetus and occurrence of macrosomia. Here, we aimed to review changes in FFAs in women with GDM and discuss the relationship of FFAs with GDM incidence and adverse outcomes.
妊娠期糖尿病(GDM)的发病率正在上升,并且与不良围产期结局以及母婴长期健康相关。GDM患者血浆游离脂肪酸(FFA)谱变化的具体机制尚不清楚。然而,人们认为饮食和脂质代谢的变化可能起了作用。脂肪酸包含许多特定的FFA,且FFA的类型对生理过程有不同影响;因此,确定个体血浆中FFA的变化至关重要。FFA浓度或谱的改变可能会促进胰岛素抵抗。此外,一些FFA显示出在妊娠早期预测GDM的潜力,并且与胎儿的生长发育及巨大儿的发生密切相关。在此,我们旨在综述GDM女性中FFA的变化,并探讨FFA与GDM发病率及不良结局的关系。